Grants and Contributions

• The CIHR HIV/AIDS Research Initiative (RI), managed by the CIHR Institute of Infection and Immunity (III), is responsible for the funding, management and oversight of research with a primary focus on HIV/AIDS and/or other STBBI (as identified in the Public Health Agency of Canada’s pan-Canadian STBBI framework for action). This includes, but is not limited to: human immunodeficiency virus (HIV), hepatitis B (HBV) and C (HCV), chlamydia, gonorrhea, syphilis, and human papilloma virus (HPV). This funding is provided across all CIHR Research Themes : biomedical research, clinical research, health services research and social, cultural, environmental and population health research.
• Research that focuses on key populations identified by Canada’s pan-Canadian STBBI framework for action is highly encouraged.
• Information on the strategic directions of the CIHR HIV/AIDS Research Initiative can be found in the CIHR HIV/AIDS Research Initiative: Strategic Plan (2015-2020).

The objectives of Stream 1 are:
•Accelerate rapid research on SARS-CoV-2 variants in Canada to contribute to the national and global efforts to address SARS-CoV-2 variants; and
•Generate timely evidence on SARS-CoV-2 variants that will show impact within 3-6 months and is relevant to biological, clinical, health system, and public health strategies.

Stream 1 applicants are strongly encouraged to consider maximizing impact by outlining how they intend to participate in:
1.The formation of a network (Stream 2) or participating in a network formed by another NPA (Stream 2); and,
2.The CIHR Network for Emerging Variants Research once established.

Canada’s Strategy for Patient-Oriented Research (SPOR) is a national coalition of federal, provincial and territorial partners (patients and informal caregivers, provincial health authorities, health centres, charities, philanthropic organizations, private sector, etc.) dedicated to the integration of research into care. Its vision is that by 2025, Canada will have demonstrably improved health outcomes and enhanced the health care experience for patients through the integration of evidence at all levels of the health care system.

As outlined in the SPOR Patient Engagement Framework, patient-oriented research refers to a continuum of research that engages patients as partners, focusses on patient-identified priorities and improves patient outcomes. This research, conducted by multidisciplinary teams in partnership with relevant stakeholders, aims to apply the knowledge generated to improve healthcare systems and practices.
As a partner in SPOR, CIHR will provide bridge funding for fundable applications that are below the competition funding cut-off and aligned with the SPOR vision and the SPOR Patient Engagement Framework. Categories are described in the Funds Available section.

The objective is to invest in targeted COVID priority research areas from the Fall 2020 Project Grant competition such as vaccine hesitancy, pregnant women and children, racialized populations, Indigenous, confidence in science and SARS-CoV-2 variants.

The Project Grant program is expected to:

• Support a diverse portfolio of health-related research and knowledge translation proposals at any stage, from discovery to application, including commercialization;
• Promote relevant collaborations across disciplines, professions, and sectors; and
• Contribute to the creation and use of health-related knowledge.

The objectives of Stream 1 are:
•Accelerate rapid research on SARS-CoV-2 variants in Canada to contribute to the national and global efforts to address SARS-CoV-2 variants; and
•Generate timely evidence on SARS-CoV-2 variants that will show impact within 3-6 months and is relevant to biological, clinical, health system, and public health strategies.

Stream 1 applicants are strongly encouraged to consider maximizing impact by outlining how they intend to participate in:
1.The formation of a network (Stream 2) or participating in a network formed by another NPA (Stream 2); and,
2.The CIHR Network for Emerging Variants Research once established.

The ICS Program is designed to foster community development by providing grants and awards to individuals and organizations for the purposes of:

• Enabling research and knowledge translation activities where the circumstances fall outside of CIHR's current suite of funding programs.

• Supporting individuals and organizations whose goals are consistent with CIHR and its Institutes' vision, mandate and strategic directions.

The ICS Program is not intended to support the direct cost of research (e.g., pilot projects, feasibility studies or operating grants), principal and co-investigator salaries or research equipment.

The specific objectives of this funding opportunity are:

• Identify wise programs, policies or actions, and/or address critical knowledge gaps, including data, related to further understanding of the immediate impacts and/or future consequences of COVID-19 among First Nations, Inuit, Métis and/or Urban Indigenous populations, communities and/or individuals;
• Identify, implement and evaluate culturally safe, and community-led solutions to address the COVID-19 pandemic and its immediate and/or future consequences among First Nations, Inuit, Métis and/or Urban Indigenous communities;
• Accelerate First Nations, Inuit, Métis and/or Urban Indigenous community-led knowledge translation and knowledge mobilization activities related to COVID-19 within the context of Indigenous health; and
• Inform and contribute to relevant research capacity and infrastructure, or adapt existing programs and infrastructure, in First Nations, Inuit, Métis and/or Urban Indigenous communities to enable Indigenous communities to design, lead, and meaningfully participate in culturally safe responses to the COVID-19 pandemic.

• This prize was established to recognize the excellence of research in aging being conducted in Canada. This prize will be given annually to the top two mid career investigators with the highest ranking projects in the Project Scheme competition that are relevant to one of the Institute of Aging’s Strategic Directions as described below:
o Strategic Direction 1: Health and Wellness over the Trajectory of Aging
Priority Areas:
¿ Life trajectory as a determinant of healthy and satisfying aging
¿ Added life to the later years
o Strategic Direction 2: Facing the Complex Health Challenges of an Older Population
Priority Areas:
¿ Understanding, preventing and addressing multiple chronic conditions
¿ Facing the challenge of dementia
¿ Recognizing new emerging aging populations
¿ Ensuring the adaptation of healthcare and services to an aging population
¿ Informing late-life care and decisions
• More information on the research priorities of CIHR-IA can be found on their website.

The objectives of Stream 1 are:
•Accelerate rapid research on SARS-CoV-2 variants in Canada to contribute to the national and global efforts to address SARS-CoV-2 variants; and
•Generate timely evidence on SARS-CoV-2 variants that will show impact within 3-6 months and is relevant to biological, clinical, health system, and public health strategies.

Stream 1 applicants are strongly encouraged to consider maximizing impact by outlining how they intend to participate in:
1.The formation of a network (Stream 2) or participating in a network formed by another NPA (Stream 2); and,
2.The CIHR Network for Emerging Variants Research once established.